A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
for Cataract
12 locations incl. Chico
Sponsor: Melt Pharmaceuticals
Sex: All·Age: 18 - 65
Code: NCT06383273·Phase 3·Recruiting·Listed Apr 2024